ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets tough cancers: early trial underway
Disease control OngoingThis study tests an experimental oral drug called silevertinib (BDTX-1535) in about 200 adults with advanced non-small cell lung cancer or glioblastoma, a type of brain cancer. The drug is designed to block specific EGFR mutations that help these cancers grow. The trial has two p…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Researchers test if electronic health records can mimic Gold-Standard cancer studies
Knowledge-focused OngoingThis study looks at whether information from electronic health records can be used to recreate the results of two earlier clinical trials (CheckMate 017 and 057) for advanced lung cancer. Researchers will compare survival outcomes in patients who started either nivolumab or docet…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC